BASKING RIDGE, N.J. & RAHWAY, N.J., June 26, 2024 – The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)...

Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had...

On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp, a bispecific CD20-directed CD3 T-cell engager,...

Updated Date: Thu, 04 Jul 2024 00:00:00 EDT

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

SA's competition watchdog has dropped its case against pharmaceutical giant Johnson & Johnson over the high price of lifesaving tuberculosis drug...

LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the...

FDA Grants Expanded Approval to Skyrizi for Ulcerative Colitis On June 18th, the U.S. Food and Drug Administration (FDA) approved AbbVie’s...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Cough in Idiopathic Pulmonary Fibrosis pipeline constitutes 5+ key...

Anyone in Stanton's emergency room during a period on June 19 was potentially exposed to an infectious case of TB. The GNWT said its advisory was...